Pouchitis - Pipeline Review, H2 2011
Global Markets Direct’s, 'Pouchitis - Pipeline Review, H2 2011', provides an overview of the Pouchitis therapeutic pipeline. This report provides information on the therapeutic development for Pouchitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pouchitis. 'Pouchitis - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- A snapshot of the global therapeutic scenario for Pouchitis.
- A review of the Pouchitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Pouchitis pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under development for Pouchitis.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisi
Pouchitis – Pipeline Review, H2 2011 Pouchitis - Pipeline Review, H2 2011 Reference Code: GMDHC1415IDB Publication Date: October 2011 Pouchitis – Pipeline Review, H2 2011 GMDHC1415IDB / Pub October 2011 © Global Markets Direct. This report is a licensed product and is not to be photocopied Page(1) Pouchitis – Pipeline Review, H2 2011 Ta b le o f Co n te n ts Table of Contents 2 List of Tables 3 List of Figures 3 Introduction 4 Global Markets Direct Report Coverage 4 Pouchitis Overview 5 Therapeutics Development 6 An Overview of Pipeline Products for Pouchitis 6 Pouchitis Therapeutics under Development by Companies 8 Mid Clinical Stage Products 9 Comparative Analysis 9 Pouchitis Therapeutics - Products under Development by Companies 10 Companies Involved in Pouchitis Therapeutics Development 11 Ocera Therapeutics, Inc. 11 Atlantic Pharmaceuticals, Inc. 11 AesRx, LLC. 12 Pouchitis - Therapeutics Assessment 13 Assessment by Monotherapy Products 13 Assessment by Route of Administration 14 Assessment by Molecule Type 16 Drug Profiles 18 Alicaforsen - Drug Profile 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 AST-120 - Drug Profile 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Aes-210 - Drug Profile 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Pouchitis Therapeutics – Drug Profile Updates 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 25 Contact Us 25 Disclaimer 25 Pouchitis – Pipeline Review, H2 2011 GMDHC1415IDB / Pub October 2011 © Global Markets Direct. This report is a licensed product and is not to be photocopied Page(2) Pouchitis – Pipeline Review, H2 2011 Lis t o f Ta b le s Number of Products Under Development for Pouchitis, H2 2011 6 Products under Development for Pouchitis – Comparative Analysis, H2 2011 7 Number of Products under Development by Companies, H2 2011
Pages to are hidden for
"Pouchitis - Pipeline Review, H2 2011"Please download to view full document